CD8A and neoplasm: The anti-tumor effect in this study was postulated to be associated with a reduction in myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs) in the tumor, activation of tumor vascular endothelial cells, and activation and recruitment of vaccine-induced CD8+ T cells into the tumor.